Astro Pharma has long been active in the field of oncology. Our oncology products have a wide range of applications, covering oncology, hematology and dermatology.
With the two biosimilars, Astro Pharma benefits from its many years of experience with high-quality follow-on biologics and thus we contribute to an expansion of therapy options and security of supply.
Areas of application are mainly non-Hodgkin lymphoma, chronic lymphocytic leukemia and HER2 positive breast cancer.
Astro Pharma has been is marketing a hedgehog inhibitor since November 2020. It is used in adults with locally advanced basal cell carcinoma for whom curative surgery or radiation therapy are out of the question.
ONCOLOGY PRODUCTS
Product name
Active substance
Herzuma® 150 mg powder for concentrate for solution for infusion
Substance: Trastuzumab
Herzuma® 420 mg powder for concentrate for solution for infusion
Substance: Trastuzumab
Odomzo 200 mg hard capsules
Substance: Sonidegib
“Pregnancy Prevention Program”
“Pregnancy Prevention Program”
Truxima® 100 mg concentrate for solution for infusion
Substance: Rituximab
“Educational Material nach EMA-Anforderung”
“Educational Material nach EMA-Anforderung”
Truxima® 500 mg concentrate for solution for infusion
Substance: Rituximab
“Educational Material nach EMA-Anforderung”
“Educational Material nach EMA-Anforderung”
The Package leaflet can be found on the website of the European Medicines Agency
(EMA).
If you have any questions about the oncologicals from Astro Pharma, please contact Dr. Sandra Frauer.
Here you will find the conditions for the exchange and return of medicines: Return conditions (only in German)